Target intelligence / Profile preview

RNA-induced silencing complex/Argonaute-2 complex (RISC/Ago2 complex) (RISC/Ago2 complex)

Target
RISC/Ago2 complex
Molecular classification
Enzyme, Ribonucleoprotein complex, Other
01

Overview

The RNA-induced silencing complex/Argonaute-2 (RISC/Ago2) complex is a multi-protein ribonucleoprotein machinery that serves as the central effector of the RNA interference (RNAi) pathway. The complex is composed of the catalytic endonuclease Argonaute-2 (Ago2) bound to a single-stranded guide RNA, such as a microRNA or small interfering RNA. The guide RNA directs the RISC/Ago2 complex to complementary target messenger RNAs (mRNAs), leading to sequence-specific mRNA cleavage, translational repression, or mRNA degradation. This machinery plays a critical role in post-transcriptional gene regulation, cellular development, and host defense against viral infections.

In disease states, dysregulation of the RISC/Ago2 complex and its associated microRNAs is implicated in oncogenesis, viral replication (such as hepatitis B and C), and neurodevelopmental disorders. The complex is highly exploited therapeutically; synthetic double-stranded siRNA drugs (such as patisiran, inclisiran, and givosiran) are designed to load into the RISC/Ago2 complex to selectively silence disease-causing genes. Additionally, small-molecule inhibitors of Ago2 (such as BCI-137 and aurintricarboxylic acid) are being investigated to block RISC assembly or miRNA loading, offering potential therapeutic strategies for cancers and other conditions driven by aberrant miRNA activity.

Other names
RISC/Ago2RNA-induced silencing complex/Argonaute 2RISC-Ago2 complexAgo2/RISC complexmiRISCArgonaute-2/RISC complex
02

Mechanism of action

Activation of the RNA interference pathway through loading of synthetic siRNA guide strands to execute sequence-specific target mRNA cleavage; or small-molecule inhibition of RISC assembly and miRNA/siRNA loading to block gene silencing.

03

Biological functions

Gene silencingRNA interferencePost-transcriptional gene regulationTranslational repressionmRNA degradationOther
04

Disease associations

CancerInfectionNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

Off-target gene silencingSaturation of endogenous RNAi machineryImmunogenicity and cytokine releaseDelivery vehicle-associated toxicitySystemic toxicity due to essential role of Ago2 in normal tissues
06

Interacting drugs

12 more in the full profile.

07

Biomarkers

Argonaute-2 expressionTarget mRNA knockdown levelsmiRNA expression profilesSTAT1 phosphorylation

Beyond the preview

Go deeper on RNA-induced silencing complex/Argonaute-2 complex (RISC/Ago2 complex) (RISC/Ago2 complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA-induced silencing complex/Argonaute-2 complex (RISC/Ago2 complex) (RISC/Ago2 complex).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call